Gastrointestinal Stromal Tumors: Update and Therapeutic Strategies
Avicenna Medical Research · 29.09.2023 · 2 (3) · 84-89
DOI: 10.34118/amr.v2i3.3518 ↗Kurz gefasst
Fachartikel in der Zeitschrift Avicenna Medical Research, online erschienen am 29.09.2023. Verfasst von A CHETIBI und 5 weiteren Autor:innen.
Abstract (Originalsprache)
AbstractGastrointestinal Stromal Tumors (GISTs) represent a significant clinical challenge due to their resistance to conventional chemotherapy. This study aims to provide an update on the clinical, morphological, pathological, and therapeutic aspects of GISTs treated at our institution over an 11-year period. We highlight the efficacy of Imatinib as a targeted therapy and emphasize the importance of complete surgical resection. Additionally, we present a case of concomitant gastric adenocarcinoma and duodenal GIST, underscoring the need for comprehensive clinical evaluation in these cases.
Zitieren
APA
CHETIBI, A., OUALID, M., GHEMIT, R., BELOUZ, R., BOUDIS, I., & SAIDANI, M. (2023). Gastrointestinal Stromal Tumors: Update and Therapeutic Strategies. Avicenna Medical Research, 2(3), 84-89. https://doi.org/10.34118/amr.v2i3.3518
Vancouver
CHETIBI A, OUALID M, GHEMIT R, BELOUZ R, BOUDIS I, SAIDANI M. Gastrointestinal Stromal Tumors: Update and Therapeutic Strategies. Avicenna Medical Research. 2023;2(3):84-89. doi:10.34118/amr.v2i3.3518
BibTeX
@article{CHETIBI2023,
author = {CHETIBI, A and OUALID, M and GHEMIT, R. and BELOUZ, R. and BOUDIS, I and SAIDANI, M},
title = {Gastrointestinal Stromal Tumors: Update and Therapeutic Strategies},
journal = {Avicenna Medical Research},
year = {2023},
volume = {2},
number = {3},
pages = {84--89},
doi = {10.34118/amr.v2i3.3518}
}
EUVIMED